{"product_id":"merck-business-model-canvas","title":"Merck \u0026 Co. Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerck \u0026amp; Co.: A Business Model Deep Dive\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Merck \u0026amp; Co.’s business model. This in-depth Business Model Canvas reveals how the company drives value through groundbreaking pharmaceuticals and vaccines, captures market share via extensive R\u0026amp;D and global distribution, and stays ahead in a competitive landscape by focusing on key therapeutic areas. Ideal for entrepreneurs, consultants, and investors looking for actionable insights into a healthcare giant.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch Institutions \u0026amp; Academia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively partners with universities and research institutions globally, fostering collaboration for early-stage drug discovery. These academic alliances are vital for tapping into cutting-edge scientific breakthroughs and specialized expertise across numerous therapeutic areas, driving innovation from fundamental research to potential new treatments.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Merck continued to invest in these key partnerships, recognizing their role in identifying novel biological targets and validating new drug candidates. For instance, collaborations with institutions like Harvard University and the University of Pennsylvania have yielded promising research in areas such as oncology and infectious diseases, contributing to Merck's robust pipeline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiotechnology \u0026amp; Pharmaceutical Companies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively cultivates key partnerships with other biotechnology and pharmaceutical companies. These alliances, often structured as licensing agreements or co-development ventures, are crucial for broadening Merck's drug development pipeline, sharing the significant costs associated with research and development, and gaining access to cutting-edge technologies and promising new compounds.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Merck continued to leverage these collaborations. For instance, a significant partnership was announced in early 2024 with a leading biotech firm to advance a novel oncology therapeutic, reflecting Merck's strategy to bolster its presence in key therapeutic areas through external innovation. These strategic alliances are vital for Merck's long-term growth and its ability to bring innovative treatments to market.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContract Research Organizations (CROs) \u0026amp; Contract Manufacturing Organizations (CMOs)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. leverages Contract Research Organizations (CROs) to outsource critical aspects of its drug development pipeline, including clinical trial management and data analysis. This strategic partnership allows Merck to access specialized expertise and scale operations efficiently, as evidenced by their ongoing collaborations with major CROs globally.\u003c\/p\u003e\n\u003cp\u003eFurthermore, Merck partners with Contract Manufacturing Organizations (CMOs) to secure specialized manufacturing capabilities for complex drug formulations and large-scale production. These CMO relationships provide essential flexibility and capacity, ensuring a robust supply chain for Merck's innovative therapies, a crucial element in meeting global demand.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnology \u0026amp; Digital Solution Providers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. is actively forging strategic alliances with technology and digital solution providers to drive its digital transformation. These partnerships are crucial for advancing smart manufacturing processes, leveraging sophisticated data analytics, and ultimately optimizing operational efficiency. A prime example is Merck’s enhanced collaboration with Siemens, focusing on implementing smart manufacturing solutions. This synergy aims to streamline production, improve quality control, and accelerate the overall drug development lifecycle.\u003c\/p\u003e\n\u003cp\u003eThese collaborations are instrumental in Merck's pursuit of innovation and operational excellence. By integrating cutting-edge digital technologies, Merck aims to gain a competitive edge in drug discovery and development. The company's investment in digital transformation initiatives underscores a commitment to utilizing technology for tangible business improvements.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigital Transformation:\u003c\/strong\u003e Partnerships with tech firms are key to modernizing Merck's operations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSmart Manufacturing:\u003c\/strong\u003e Collaborations like the one with Siemens aim to create more efficient and intelligent production facilities.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eData Analytics:\u003c\/strong\u003e Leveraging advanced data analytics through these partnerships helps optimize research, development, and manufacturing processes.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEfficiency and Acceleration:\u003c\/strong\u003e The ultimate goal is to boost operational efficiency and speed up the delivery of new therapies to patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Providers \u0026amp; Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively partners with healthcare providers and organizations, including hospitals and clinics, to conduct vital real-world evidence studies.  These collaborations are crucial for understanding how Merck's treatments perform in everyday clinical settings and for gathering data on patient outcomes. For instance, in 2024, Merck continued its commitment to real-world data generation, leveraging partnerships to inform product development and patient access strategies.\u003c\/p\u003e\n\u003cp\u003eThese alliances also facilitate the implementation of patient access programs, ensuring that individuals can benefit from Merck's innovations. By working closely with healthcare systems, Merck gains invaluable insights into the practical application and effectiveness of its medicines.  This symbiotic relationship helps ensure that Merck's pharmaceutical offerings are aligned with the evolving needs of both patients and the broader healthcare landscape.\u003c\/p\u003e\n\u003cp\u003eKey aspects of these partnerships include:\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eReal-world data collection:\u003c\/strong\u003e Gathering evidence on treatment efficacy and safety in diverse patient populations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePatient access programs:\u003c\/strong\u003e Collaborating to improve affordability and accessibility of medications.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eClinical insights:\u003c\/strong\u003e Obtaining feedback on treatment protocols and patient experiences to refine offerings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eOutcome measurement:\u003c\/strong\u003e Tracking the impact of Merck's products on patient health and healthcare system efficiency.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic Partnerships Advance 2024 Drug Discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. collaborates with academic institutions and research organizations for early-stage drug discovery, tapping into cutting-edge science.  In 2024, these partnerships, including those with Harvard and the University of Pennsylvania, yielded promising research in oncology and infectious diseases, bolstering Merck's pipeline.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written business model tailored to Merck \u0026amp; Co.'s strategy, focusing on its pharmaceutical and animal health divisions.\u003c\/p\u003e\n\u003cp\u003eCovers customer segments like healthcare providers and patients, key channels such as direct sales and distributors, and value propositions centered on innovative drug development and disease treatment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eMerck \u0026amp; Co.'s Business Model Canvas acts as a pain point reliever by providing a clear, structured overview of their complex pharmaceutical operations, enabling faster identification of inefficiencies and strategic opportunities.\u003c\/p\u003e\n\u003cp\u003eIt offers a concise, one-page snapshot of Merck's value proposition, customer segments, and key resources, simplifying the challenge of navigating the intricate healthcare landscape and accelerating strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development (R\u0026amp;D)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerck's research and development is the engine driving its business, focusing on discovering and bringing to market new medicines and vaccines. This process is complex, involving everything from early-stage lab work to rigorous clinical trials.  In 2023, Merck reported R\u0026amp;D expenses of approximately $13.5 billion, underscoring its significant investment in innovation.\u003c\/p\u003e\n\u003cp\u003eThe company's R\u0026amp;D pipeline is crucial for future growth, covering a wide range of therapeutic areas like oncology, vaccines, and animal health.  This investment is essential for navigating the lengthy and costly process of drug development, which includes multiple phases of clinical testing and regulatory review before a product can reach patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Supply Chain Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerck's key activities in manufacturing and supply chain management are central to its business model, encompassing the large-scale production of a wide array of pharmaceuticals, vaccines, and animal health products. This operational backbone ensures that life-saving and health-improving innovations reach global markets. \u003c\/p\u003e\n\u003cp\u003eThe company manages a sophisticated and extensive global supply chain, a critical component for the efficient and reliable distribution of its diverse product portfolio. This network is designed to navigate complex logistical challenges, ensuring timely delivery to healthcare providers and patients worldwide. \u003c\/p\u003e\n\u003cp\u003eIn 2023, Merck reported significant investments in its manufacturing capabilities, aiming to enhance capacity and efficiency across its operations. The company's commitment to supply chain resilience was further underscored by its ongoing efforts to diversify sourcing and strengthen distribution networks, particularly in response to evolving global health demands. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMarketing, Sales, and Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively markets and sells its pharmaceutical and vaccine products worldwide, targeting healthcare providers, hospitals, and patients. Their strategy involves a substantial global sales force, extensive digital marketing campaigns, and robust management of distribution channels to guarantee widespread product accessibility across diverse geographical markets.\u003c\/p\u003e\n\u003cp\u003eIn 2024, Merck continued to invest heavily in its commercial operations. For instance, their Keytruda franchise, a cornerstone of their oncology portfolio, saw significant global sales growth, underscoring the effectiveness of their targeted marketing and sales efforts in key therapeutic areas. The company reported approximately $26.3 billion in Keytruda sales for 2024, highlighting the success of their go-to-market strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePortfolio Management and Business Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively refines its product portfolio through strategic acquisitions and divestitures. This approach aims to bolster its presence in high-growth therapeutic areas and expand its overall treatment capabilities. For instance, the 2024 acquisition of SpringWorks Therapeutics significantly enhances Merck's pipeline in rare tumors.\u003c\/p\u003e\n\u003cp\u003eFurthermore, the acquisition of Verona Pharma in 2024 strengthens Merck's position in the cardiopulmonary market, demonstrating a commitment to expanding its therapeutic reach. These moves are crucial for maintaining a competitive edge and driving future revenue growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePortfolio Optimization:\u003c\/strong\u003e Merck continuously evaluates its product offerings, divesting non-core assets and acquiring promising new ones.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStrategic Acquisitions:\u003c\/strong\u003e Recent examples like SpringWorks Therapeutics and Verona Pharma highlight a focus on strengthening specific therapeutic pipelines.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGrowth Focus:\u003c\/strong\u003e These activities are designed to concentrate resources on areas with high growth potential and unmet medical needs.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePipeline Enhancement:\u003c\/strong\u003e The business development strategy directly supports the expansion and strengthening of Merck's drug development pipeline.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Affairs and Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerck \u0026amp; Co. actively manages regulatory affairs and compliance, a crucial activity given the highly regulated nature of the pharmaceutical industry. This involves meticulously preparing and submitting extensive dossiers to health authorities worldwide for new drug approvals.  In 2023, Merck reported substantial investments in research and development, a significant portion of which is allocated to navigating these complex regulatory pathways. For instance, the company's ongoing efforts to secure approvals for its oncology pipeline, including Keytruda in new indications, underscore the importance of this function.\u003c\/p\u003e\n\u003cp\u003eEnsuring ongoing compliance with evolving health and safety regulations is paramount. This includes adhering to Good Manufacturing Practices (GMP), pharmacovigilance requirements, and post-market surveillance mandates across all operating regions. Merck’s commitment to compliance is reflected in its robust internal systems and dedicated teams focused on monitoring and adapting to regulatory changes, thereby safeguarding product integrity and patient safety.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlobal Regulatory Submissions:\u003c\/strong\u003e Preparing and submitting dossiers for new drug applications and label expansions to agencies like the FDA, EMA, and PMDA.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Market Surveillance:\u003c\/strong\u003e Monitoring and reporting adverse events, conducting risk management activities, and ensuring continued product safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCompliance Audits:\u003c\/strong\u003e Regularly undergoing internal and external audits to verify adherence to all applicable healthcare laws and regulations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePolicy Engagement:\u003c\/strong\u003e Participating in industry dialogues to shape regulatory policies and ensure a predictable operating environment.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharma's Core: R\u0026amp;D, Production, and Strategic Market Expansion\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerck’s key activities revolve around its robust research and development pipeline, focused on discovering and commercializing innovative medicines and vaccines. This includes extensive clinical trials and navigating complex regulatory approvals. The company also engages in strategic business development, actively pursuing acquisitions and divestitures to enhance its product portfolio and therapeutic reach.\u003c\/p\u003e\n\u003cp\u003eMerck's manufacturing and supply chain operations are critical for producing and distributing its diverse range of pharmaceutical products globally. In 2023, Merck invested significantly in enhancing its manufacturing capabilities and supply chain resilience to meet growing demand. The company also focuses on aggressive marketing and sales strategies, particularly for its blockbuster oncology drugs like Keytruda, which generated approximately $26.3 billion in sales in 2024.\u003c\/p\u003e\n\u003cp\u003eRegulatory affairs and compliance are paramount, involving meticulous preparation of submissions for new drug approvals and ongoing monitoring of product safety. Merck's commitment to compliance ensures adherence to global health and safety regulations, including Good Manufacturing Practices. The company’s strategic acquisitions in 2024, such as SpringWorks Therapeutics and Verona Pharma, underscore its focus on strengthening key therapeutic areas and driving future growth.\u003c\/p\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThis preview showcases the actual Merck \u0026amp; Co. Business Model Canvas you will receive upon purchase. It is not a sample or mockup, but a direct representation of the complete document, ensuring you know exactly what you're getting. Once your order is processed, you'll gain full access to this professionally structured and ready-to-use analysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":55611230716281,"sku":"merck-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/merck-business-model-canvas.png?v=1754753382","url":"https:\/\/growthsharematrix.com\/products\/merck-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}